Extracellular vesicles and ctDNA in lung cancer: biomarker sources and therapeutic applications Chengliang HuangSitong LiuHong Fan Review Article 08 June 2018 Pages: 171 - 183
The natural agent 4-vinylphenol targets metastasis and stemness features in breast cancer stem-like cells Hoi-Wing LeungChun-Hay KoClara Bik-San Lau Original Article 18 May 2018 Pages: 185 - 197
Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro Jia-Feng HuangChun-Jie WenHong-Hao Zhou Original Article 18 May 2018 Pages: 199 - 210
Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel Matthew ScarpelliMurtuza RampurwalaJustine Yang Bruce Original Article 25 May 2018 Pages: 211 - 219
Relationship of peak serum methotrexate concentration to prognosis and drug tolerance in non-metastatic extremity osteosarcomas Bo WangHao YaoJingnan Shen Original Article 28 May 2018 Pages: 221 - 227
Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia Chunlu GaoShuang HuJin Zhou Original Article 29 May 2018 Pages: 229 - 236
The association of polymorphisms in folate-metabolizing genes with response to adjuvant chemotherapy of colorectal cancer Al-Motassem YousefMohammed ZawiahHanguin Al-Ramadhani Original Article 29 May 2018 Pages: 237 - 243
Gemcitabine plus nab-paclitaxel vs. FOLFIRINOX for patients with advanced pancreatic cancer Junko TaharaKyoko ShimizuKatsutoshi Tokushige Original Article 30 May 2018 Pages: 245 - 250
Targeting ALK in pediatric RMS does not induce antitumor activity in vivo Monika WierdlLyudmila TsurkanPhilip M. Potter Original Article 31 May 2018 Pages: 251 - 263
Pulmonary administration of curcumin inhibits B16F10 melanoma lung metastasis and invasion in mice Ken ShimadaKentaro UshijimaAkio Fujimura Original Article 04 June 2018 Pages: 265 - 273
Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study Sakura IizumiAkihiko ShimomuraKenji Tamura Original Article Open access 05 June 2018 Pages: 275 - 283
Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer Jordi RodonAlejandro Pérez-FidalgoJose Baselga Original Article 07 June 2018 Pages: 285 - 298
The pH-altering agent omeprazole affects rate but not the extent of ibrutinib exposure Jan de JongNahor Haddish-BerhaneDaniele Ouellet Original Article 07 June 2018 Pages: 299 - 308
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors Amikar SehdevTheodore KarrisonManish R. Sharma Original Article 09 June 2018 Pages: 309 - 317
Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients Olivia Le SauxAurélie BourmaudVéronique Trillet-Lenoir Original Article 15 June 2018 Pages: 319 - 327
Pharmacokinetic and pharmacodynamic bioequivalence study of a pegfilgrastim biosimilar INTP5 in healthy subjects Inderjeet SinghAkash PatelVinu Jose Original Article 15 June 2018 Pages: 329 - 337
Phase I study of the anti-α5β1 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors Colin D. WeekesLee S. RosenAlberto Bessudo Original Article 15 June 2018 Pages: 339 - 351
Phase II study of pazopanib in combination with paclitaxel in patients with metastatic melanoma John P. FruehaufMonica El-MasryJames G. Jakowatz Clinical Trial Report Open access 25 June 2018 Pages: 353 - 360
Therapeutic drug monitoring and dose adaptation of cisplatin in a newborn with hepatoblastoma: a case report Fabienne ThomasGareth J. VealChristophe Piguet Short Communication 19 June 2018 Pages: 361 - 365
Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma Jie WengMengyun TuZhiyi Wang Letter to the Editor 15 March 2018 Pages: 367 - 367
Reply to: Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma Kyoichi Kaira Letter to the Editor 25 June 2018 Pages: 369 - 369
